|1.37|| -0.02 / -1.44%|
Neptune Technologies & Bioresources, Inc. is a biotechnology company engaged primarily in the development and commercialization of marine derived omega-3 polyunsaturated fatty acids. The company operates through three segments: Neptune, Acasti and NeuroBio. The Neptune segment involves the production and commercialization of nutraceutical products. The Acasti segment involves the development and commercialization of medical food and pharmaceutical products for cardiovascular diseases. The NeuroBio segment involves the development of medical food and pharmaceutical products for neurological diseases. Neptune Technologies & Bioresources was founded by Henri Harland on October 9, 1998 and is headquartered in Laval, Canada.
|Jim Hamilton||President, Chief Executive Officer & Director|
|Wael Massrieh||Vice President-Scientific Affairs|
|Michel Timperio||Head-Strategic Development|
|Jacqueline Khayat||Sales Director|
|John R. Ripplinger||Director-Investor Relations|